0001209191-21-067867.txt : 20211203 0001209191-21-067867.hdr.sgml : 20211203 20211203170254 ACCESSION NUMBER: 0001209191-21-067867 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211201 FILED AS OF DATE: 20211203 DATE AS OF CHANGE: 20211203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brandenberger Ralph CENTRAL INDEX KEY: 0001853197 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39370 FILM NUMBER: 211470883 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT, SUITE 102 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nkarta, Inc. CENTRAL INDEX KEY: 0001787400 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474515206 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6000 SHORELINE COURT STREET 2: SUITE 102 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-582-4923 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT STREET 2: SUITE 102 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-12-01 0 0001787400 Nkarta, Inc. NKTX 0001853197 Brandenberger Ralph 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Sr. VP, Technical Operations Common Stock 2021-12-01 4 M 0 340 0.41 A 340 D Common Stock 2021-12-01 4 M 0 405 4.77 A 745 D Common Stock 2021-12-01 4 M 0 1358 3.89 A 2103 D Common Stock 2021-12-01 4 M 0 2037 3.89 A 4140 D Common Stock 2021-12-01 4 S 0 4140 15.64 D 0 D Stock Option (right to buy) 0.41 2021-12-01 4 M 0 340 0.00 D 2028-07-18 Common Stock 340 7707 D Stock Option (right to buy) 4.77 2021-12-01 4 M 0 405 0.00 D 2029-05-10 Common Stock 405 9190 D Stock Option (right to buy) 3.89 2021-12-01 4 M 0 1358 0.00 D 2029-09-05 Common Stock 1358 30784 D Stock Option (right to buy) 3.89 2021-12-01 4 M 0 2037 0.00 D 2029-09-05 Common Stock 2037 46176 D The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. This transaction was executed in multiple trades at prices ranging from $15.26 to $16.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on April 2, 2022. The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on December 6, 2022. The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on July 1, 2024. The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on September 5, 2023. /s/ Alicia Hager, as Attorney-in-Fact 2021-12-03